1. Turkel SB, Trzepacz PT, Tavaré CJ. Comparing symptoms of delirium in adults and children. Psychosomatics. 2006;47:320-324.
2. Kurtz BP, Abrams AN. Psychiatric aspects of pediatric cancer. Child Adolesc Psychiatr Clin N Am. 2010;19:401-421, x-xi.
3. Martini DR, Pao M. Psychiatric emergencies. In: Wiener LS, Pao M, Kazak AE, et al, eds. Quick Reference for Pediatric Oncology Clinicians: The Psychiatric and Psychological Dimensions of Pediatric Cancer Symptom Management. Charlottesville, VA: IPOS Press; 2009:121-129.
4. Apter A, Farbstein I, Yaniv I. Psychiatric aspects of pediatric cancer. Child Adolesc Psychiatr Clin N Am. 2003;12:473-492, vii.
5. Karnik NS, Joshi SV, Paterno C, Shaw R. Subtypes of pediatric delirium: a treatment algorithm. Psychosomatics. 2007;48:253-257.
6. Schieveld JN, Leroy PL, van Os J, et al. Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Med. 2007;33:1033-1040.
7. Munzig E, Turkel S, Jacobson J, et al. Diagnosis and treatment of pediatric delirium. Poster presented at: Academy of Psychosomatic Medicine; November 20, 2008; Miami.
8. de Jonge PD, Hadj FB, Boffa D, et al. Prevention of major depression in complex medically ill patients: preliminary results from a randomized, controlled trial. Psychosomatics. 2009;50:227-233.
9. Koopmans GT, Donker MC, Rutten FH. Length of hospital stay and health service use of medical inpatients with comorbid noncognitive mental disorders: a review of the literature. Gen Hosp Psychiatry. 2005;27:44-56.
10. Fenton WS, Stover ES. Mood disorders: cardiovascular and diabetes comorbidity. Curr Opin Psychiatry. 2006;19:421-427.
11. Garrison MM, Katon WJ, Richardson LP. The impact of psychiatric comorbidities on readmissions for diabetes in youth. Diabetes Care. 2005;28:2150-2154.
12. Kersun LS, Elia J. Depressive symptoms and SSRI use in pediatric oncology patients. Pediatr Blood Cancer. 2007;49:881-887.
13. Szigethy E, Levy-Warren A, Whitton S, et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr. 2004;39:395-403.
14. Pao M, Lyon M, D’Angelo LJ, et al. Psychiatric diagnoses in adolescents seropositive for the human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000;154:240-244.
15. Ballard E, Bosk A, Snyder D, et al. Patients’ opinions about suicide screening in a pediatric emergency department. Pediatr Emerg Care. In press.
16. Gothelf D, Rubinstein M, Shemesh E, et al. Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer. J Am Acad Child Adolesc Psychiatry. 2005;44:1258-1262.
17. DeJong M, Fombonne E. Citalopram to treat depression in pediatric oncology. J Child Adolesc Psychopharmacol. 2007;17:371-377.
18. Indiana University School of Medicine, Division of Clinical Pharmacology. P450 Drug Interaction Table. Accessed September 28, 2011.
19. US Food and Drug Administration. FDA Drug Safety Communication: Abnormal Heart Rhythms Associated With High Doses of Celexa (Citalopram Hydrobromide). August 2011. Accessed September 28, 2011.
20. Stuber ML, Seacord D. Psychiatric impact of childhood cancer. In: Kreitler S, Ben Arush MW, eds. Psychosocial Aspects of Pediatric Oncology. West Sussex, England: John Wiley & Sons Ltd; 2004:211-228.
21. Kendall PC, Flannery-Schroeder E, Panichelli-Mindel SM, et al. Therapy for youths with anxiety disorders: a second randomized clinical trial. J Consult Clin Psychol. 1997;65:366-380.
22. Patel A, Schieble T, Davidson M, et al. Distraction with a hand-held video game reduces pediatric preoperative anxiety. Paediatr Anaesth. 2006;16:1019-1027.
23. US Food and Drug Administration. FDA Approved Drug Products. Accessed October 7, 2011.